Use App
AI Agent
Trending
News
Earnings
All
DIA
0.36%
SPY
0.20%
QQQ
0.06%
Trending
JASMY
16.02%
MU
0.25%
QNT
0.85%
DOGE
1.13%
SLV
1.48%
CAPR
7.18%
SMCI
1.29%
AVT
55.42%
CVX
0.08%
ONDO
8.72%
Feed
News
Sentiment
Earnings
Fundamentals
Info
home
Symbol
GMED
news
Exchange:
NYSE
·
Updated 07:55 PM EDT
GMED News
News
all
press releases
Veeva Unveils AI Study Builder Agent to Speed Clinical Trial Setup
VEEV's AI-powered Study Builder Agent automates clinical study setup, cutting manual work while strengthening its connected Clinical Data ecosystem.
Zacks
Share to Feed
Veeva Unveils AI Study Builder Agent to Speed Clinical Trial Setup
VEEV's AI-powered Study Builder Agent automates clinical study setup, cutting manual work while strengthening its connected Clinical Data ecosystem.
Zacks
Share to Feed
More News
RVTY Launches New Kit in Europe for Newborn Type 1 Diabetes Detection
Revvity launches a CE-IVDR-certified automated T1D screening kit for children, expanding its GSP platform from newborn screening into early childhood.
Zacks
Quest Diagnostics Stock Gains 36.3% YTD: What's Behind the Rally?
DGX's 36.3% YTD rise reflects momentum in advanced diagnostics, channel growth, AI adoption and cost savings.
Zacks
Here's Why You Should Hold QIAGEN Stock in Your Portfolio for Now
QGEN's test menu expansion and strategic partnerships support growth, but cautious spending and competition may weigh on near-term gains.
Zacks
Here's Why You Should Retain Glaukos Stock in Your Portfolio for Now
Glaukos' iDose and Epioxa are driving growth, while recurring treatments, high margins and a broad pipeline support its long-term prospects.
Zacks
Illumina Stock Surges 94.9% YTD: What's Behind the Rally?
ILMN's 94.9% YTD rally reflects strong sequencing growth, clinical adoption and a raised 2026 outlook despite China headwinds.
Zacks
Here's Why You Should Retain Baxter Stock in Your Portfolio for Now
BAX's portfolio reset and growth in connected care and advanced surgery support prospects, but margins, Novum IQ and China pricing remain risks.
Zacks
COO Unveils New Innovation Hub & Lens Launch Plans to Aid CooperVision
The Cooper Companies opens a global innovation hub in England and unveils six contact lens programs to support sustainable long-term growth.
Zacks
Veeva Unveils Falcon Router to Streamline Biopharma Case Routing
VEEV launches Falcon Router to automate biopharma case routing, deepening AI integration across regulated life sciences workflows.
Zacks
Here's Why You Should Hold Bio-Rad Stock in Your Portfolio for Now
BIO's Clinical Diagnostics strength and international reach support growth, while China weakness, geopolitics and FX remain key risks.
Zacks
1
2
Advertisement
|
Remove ads.
Home
Watchlist
Trending
News
Explore
Profile